miltefosine
CHEBI:CHEBI_75283
Definition
A phospholipid that is the hexadecyl monoester of phosphocholine.
Chemical Information
- Molecular Formula
- C21H46NO4P
- Molecular Mass
- 407.56800
- Charge
- 0
- SMILES
- CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
- InChI
- InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3
- InChIKey
- PQLXHQMOHUQAKB-UHFFFAOYSA-N
Alternative Names
- Hexadecylphosphocholine
- Hexadecylphosphorylcholine
- miltefosina
- miltefosine
- miltefosinum
- monohexadecylphosphocholine
- monohexadecylphosphorylcholine
Drug Classification
-
t286106
-
t286195
-
t286304
-
t286593
-
t286890
-
t287112
-
t287119
-
t285777
-
phospholipidView Class →
CHEBI:16247
-
PhospholipidsView Class →
CHEBI:16247
-
phosphocholinesView Class →
CHEBI:36700
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:75283
- DRON_00010000
- 1494066
- oboInOwl#hasDbXref
- Wikipedia:Miltefosine
Additional References
Wikipedia:Miltefosine
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- core#notation
- CHEBI:75283
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 1494066
- oboInOwl#hasDbXref
- Wikipedia:Miltefosine
- oboInOwl#id
- CHEBI:75283
- generic_name
- Miltefosine
- rxcui
- 1495070
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- route
- ORAL
- listing_expiration_date
- 20241231
- dosage_form
- CAPSULE
- active_ingredient_strength
- 5 g/5g
- marketing_start_date
- 20151029
- labeler_name
- Profounda, Inc.
- package_marketing_start_date
- 07-JAN-20
- brand_name
- IMPAVIDO
- brand_name_base
- IMPAVIDO
- product_ndc
- 71052-509
- application_number
- NDA204684
- manufacturer_name
- Profounda, Inc.
- spl_id
- 092d5414-6211-61bd-e063-6394a90a0100
- active_ingredient_name
- MILTEFOSINE
- package_ndc
- 71052-509-50
- package_description
- 50 g in 1 CONTAINER (71052-509-50)
- unii
- 53EY29W7EC
- spl_set_id
- bcb387ac-2e90-4f5e-94b2-d3635190678e
- nui
- N0000190851
- pharm_class_epc
- Antileishmanial [EPC]
- pharm_class
- Antileishmanial [EPC]
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_37699
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- has_treatment
- http://purl.obolibrary.org/obo/DOID_9065
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect34241
- owl#annotatedSource
- t287131
- owl#someValuesFrom
- t2910022